Brincidofovir-d6
Brincidofovir-d6 (CMX001-d6) is the deuterium labeled Brincidofovir. Brincidofovir (CMX001), the lipid-conjugated prodrug of Cidofovir (HY-17438), is an orally available, long-acting antiviral. Brincidofovir shows activity against a broad spectrum of DNA viruses including cytomegalovirus (CMV), adenovirus (ADV), varicella zoster virus, herpes simplex virus, polyomaviruses, papillomaviruses, poxviruses, and mixed double-stranded DNA virus infections. Brincidofovir, an oral antiviral in late stage development, has proven effective against orthopoxviruses in vitro and in vivo.[1][2][3][4].
Product Specifications
CAS Number
1917374-64-1
Product Name Alternative
CMX001-d6; HDP-CDV-d6
UNSPSC
12352005
Target
CMV; HSV; Isotope-Labeled Compounds; Orthopoxvirus
Related Pathways
Anti-infection; Others
Field of Research
Infection
Smiles
NC1=NC(N(C[C@@H](CO)OCP(O)(OC([2H])([2H])C([2H])([2H])C([2H])([2H])OCCCCCCCCCCCCCCCC)=O)C=C1)=O
Molecular Formula
C27H46D6N3O7P
Molecular Weight
567.73
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
HighYield T7 AZDye647 RNA Labeling Kit (CTP-based)
